ArticleFrontiers in oncology2020

Dual Tracers of 16α-[18F]fluoro-17β-Estradiol and [18F]fluorodeoxyglucose for Prediction of Progression-Free Survival After Fulvestrant Therapy in Patients With HR+/HER2- Metastatic Breast Cancer.

Cheng Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.